Does DILTIAZEM Cause Mobility decreased? 770 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 770 reports of Mobility decreased have been filed in association with DILTIAZEM (Cardizem CD). This represents 5.2% of all adverse event reports for DILTIAZEM.
770
Reports of Mobility decreased with DILTIAZEM
5.2%
of all DILTIAZEM reports
202
Deaths
671
Hospitalizations
How Dangerous Is Mobility decreased From DILTIAZEM?
Of the 770 reports, 202 (26.2%) resulted in death, 671 (87.1%) required hospitalization, and 211 (27.4%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DILTIAZEM. However, 770 reports have been filed with the FAERS database.
What Other Side Effects Does DILTIAZEM Cause?
Completed suicide (1,696)
Toxicity to various agents (1,663)
Hypotension (1,550)
Dyspnoea (1,436)
Drug ineffective (1,315)
Fall (1,262)
Pain (1,169)
Dizziness (1,091)
Fatigue (1,054)
Headache (874)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DILTIAZEM Alternatives Have Lower Mobility decreased Risk?
DILTIAZEM vs DIMENHYDRINATE
DILTIAZEM vs DIMETHICONE
DILTIAZEM vs DIMETHICONE\LOPERAMIDE
DILTIAZEM vs DIMETHINDENE
DILTIAZEM vs DIMETHYL